ImmunityBio Inc (NASDAQ: IBRX) on Monday, plunged -4.67% from the previous trading day, before settling in for the closing price of $2.14. Within the past 52 weeks, IBRX’s price has moved between $1.83 and $4.27.
During the last 5-year period, the sales growth of Healthcare Sector giant was 2.39%. The company achieved an average annual earnings per share of 27.10%. With a float of $330.78 million, this company’s outstanding shares have now reached $984.97 million.
ImmunityBio Inc (IBRX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of ImmunityBio Inc is 66.42%, while institutional ownership is 14.61%.
ImmunityBio Inc (IBRX) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.08 earnings per share (EPS) for the period topping the consensus outlook (set at -0.13) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 66.49% during the next five years compared to 2.39% growth over the previous five years of trading.
ImmunityBio Inc (NASDAQ: IBRX) Trading Performance Indicators
ImmunityBio Inc (IBRX) is currently performing well based on its current performance indicators. A quick ratio of 5.65 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.42, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of ImmunityBio Inc (IBRX)
Looking closely at ImmunityBio Inc (NASDAQ: IBRX), its last 5-days average volume was 10.75 million, which is a jump from its year-to-date volume of 8.9 million. As of the previous 9 days, the stock’s Stochastic %D was 25.04%.
During the past 100 days, ImmunityBio Inc’s (IBRX) raw stochastic average was set at 8.82%, which indicates a significant increase from 8.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.13 in the past 14 days, which was higher than the 0.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.22, while its 200-day Moving Average is $2.54. However, in the short run, ImmunityBio Inc’s stock first resistance to watch stands at $2.11. Second resistance stands at $2.18. The third major resistance level sits at $2.22. If the price goes on to break the first support level at $2.00, it is likely to go to the next support level at $1.96. Should the price break the second support level, the third support level stands at $1.89.
ImmunityBio Inc (NASDAQ: IBRX) Key Stats
Market capitalization of the company is 2.01 billion based on 984,965K outstanding shares. Right now, sales total 14,750 K and income totals -413,560 K. The company made 32,060 K in profit during its latest quarter, and -67,250 K in sales during its previous quarter.
